| Jay Austin Clark, MD | |
|
170 N 1100 E, American Fork, UT 84003-2096 | |
| (801) 357-2480 | |
| Not Available |
| Full Name | Jay Austin Clark |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 31 Years |
| Location | 170 N 1100 E, American Fork, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952329088 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 4939552-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Utah Valley Hospital | Provo, UT | Hospital |
| American Fork Hospital | American fork, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
In a country that leads in infant mortality rates, the Bayat Foundation inaugurated the construction of a maternity hospital in a ceremony with local officials. Named "Gawhartaj Bayat", this much needed facility will accommodate space for 20 beds, a pharmacy, laboratory, and include modern equipment. The project is scheduled to be complete and open for care by October 1, 2010 in Gardez, the capital of the southeast province of Paktia in Afghanistan.
GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion, recommending marketing authorisation for BENLYSTA (belimumab) as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.
France's Sanofi-Pasteur, the world's largest vaccine maker, said Friday it hopes to introduce a dengue vaccine in 2014 to some high-risk nations, AlertNet reports. The vaccine is in the last stage of clinical testing in Australia, and the company said it hopes to produce 100 million doses of the vaccine annually, according to the news agency.
A global study of nearly 10,000 women with early breast cancer has found wide variations in how they were treated, despite international consensus on best practice, according to the May issue of the British Journal of Surgery.
› Verified 2 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
In a country that leads in infant mortality rates, the Bayat Foundation inaugurated the construction of a maternity hospital in a ceremony with local officials. Named "Gawhartaj Bayat", this much needed facility will accommodate space for 20 beds, a pharmacy, laboratory, and include modern equipment. The project is scheduled to be complete and open for care by October 1, 2010 in Gardez, the capital of the southeast province of Paktia in Afghanistan.
GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion, recommending marketing authorisation for BENLYSTA (belimumab) as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.
France's Sanofi-Pasteur, the world's largest vaccine maker, said Friday it hopes to introduce a dengue vaccine in 2014 to some high-risk nations, AlertNet reports. The vaccine is in the last stage of clinical testing in Australia, and the company said it hopes to produce 100 million doses of the vaccine annually, according to the news agency.
A global study of nearly 10,000 women with early breast cancer has found wide variations in how they were treated, despite international consensus on best practice, according to the May issue of the British Journal of Surgery.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay Austin Clark, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 357-2480 | Jay Austin Clark, MD 170 N 1100 E, American Fork, UT 84003-2096 Ph: (801) 357-2480 |
News Archive
In a country that leads in infant mortality rates, the Bayat Foundation inaugurated the construction of a maternity hospital in a ceremony with local officials. Named "Gawhartaj Bayat", this much needed facility will accommodate space for 20 beds, a pharmacy, laboratory, and include modern equipment. The project is scheduled to be complete and open for care by October 1, 2010 in Gardez, the capital of the southeast province of Paktia in Afghanistan.
GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion, recommending marketing authorisation for BENLYSTA (belimumab) as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.
France's Sanofi-Pasteur, the world's largest vaccine maker, said Friday it hopes to introduce a dengue vaccine in 2014 to some high-risk nations, AlertNet reports. The vaccine is in the last stage of clinical testing in Australia, and the company said it hopes to produce 100 million doses of the vaccine annually, according to the news agency.
A global study of nearly 10,000 women with early breast cancer has found wide variations in how they were treated, despite international consensus on best practice, according to the May issue of the British Journal of Surgery.
› Verified 2 days ago
Brandon M Barney, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-357-2480 | |
Dr. Jason Howard Eves, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1175 E 50 S Ste 141, American Fork, UT 84003 Phone: 801-492-5996 |